SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $46,902,000 | +1.4% | 46,902,000 | 0.0% | 3.79% | -5.0% |
Q4 2022 | $46,257,098 | +0.9% | 46,902,000 | 0.0% | 3.99% | -6.0% |
Q3 2022 | $45,824,000 | +0.2% | 46,902,000 | 0.0% | 4.24% | -3.5% |
Q2 2022 | $45,737,000 | -1.5% | 46,902,000 | 0.0% | 4.40% | +17.6% |
Q1 2022 | $46,433,000 | +2.8% | 46,902,000 | +3.3% | 3.74% | +9.2% |
Q4 2021 | $45,147,000 | +0.7% | 45,402,000 | 0.0% | 3.42% | -18.6% |
Q3 2021 | $44,828,000 | +21.0% | 45,402,000 | +21.6% | 4.21% | +5.9% |
Q2 2021 | $37,062,000 | +2.0% | 37,347,000 | 0.0% | 3.97% | -10.4% |
Q1 2021 | $36,345,000 | -1.7% | 37,347,000 | -3.7% | 4.44% | +7.7% |
Q4 2020 | $36,963,000 | -4.5% | 38,801,000 | -7.2% | 4.12% | -13.0% |
Q3 2020 | $38,713,000 | +3.6% | 41,818,000 | +99876.1% | 4.74% | -25.8% |
Q2 2020 | $37,385,000 | +10.9% | 41,828 | +2.0% | 6.39% | -7.6% |
Q1 2020 | $33,718,000 | +287.5% | 41,026 | +329.1% | 6.91% | +427.8% |
Q4 2019 | $8,701,000 | – | 9,562 | – | 1.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 45,402,000 | $44,828,000 | 4.21% |
Radcliffe Capital Management, L.P. | 69,010,000 | $67,802,000 | 1.97% |
Penn Mutual Asset Management | 675 | $672,000 | 1.06% |
CAMDEN ASSET MANAGEMENT L P /CA | 24,548,000 | $24,118,000 | 0.95% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 38,428,000 | $38,079,000 | 0.87% |
DeepCurrents Investment Group LLC | 21,155,000 | $20,805,000 | 0.62% |
SHENKMAN CAPITAL MANAGEMENT INC | 6,813,000 | $6,618,000 | 0.51% |
OAKTREE CAPITAL MANAGEMENT LP | 22,348,000 | $22,068,000 | 0.31% |
WOLVERINE ASSET MANAGEMENT LLC | 16,540,000 | $16,325,000 | 0.14% |
AVIVA PLC | 17,300,000 | $16,926,000 | 0.08% |